Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Neil B Desai"'
Autor:
Osama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, Andrew Leiker, Alana Christie, Elizabeth Zhang-Velten, Lakshya Trivedi, Saad Khan, Neil B Desai, Aaron Laine, Kevin Albuquerque, Puneeth Iyengar, Yull Arriaga, Kevin Courtney, David E. Gerber, Hans Hammers, Hak Choy, Robert Timmerman, James Brugarolas, Raquibul Hannan
Publikováno v:
OncoImmunology, Vol 7, Iss 7 (2018)
Integration of hypofractionated body radiotherapy (H-RT) into immune checkpoint inhibitor (ICI) therapy may be a promising strategy to improve the outcomes of ICIs, although sufficient data is lacking regarding the safety and efficacy of this regimen
Externí odkaz:
https://doaj.org/article/1b440311a27840808257a962dd3e4584
Autor:
Craig E. Grossman, MD, PhD, MSCE, Michael R. Folkert, MD, Stephanie Lobaugh, MS, Neil B. Desai, MD, MHS, Marisa A. Kollmeier, MD, Daniel Gorovets, MD, Sean M. McBride, MD, MPH, Robert D. Timmerman, MD, Zhigang Zhang, PhD, Michael J. Zelefsky, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101070- (2023)
Purpose: Although hydrogel spacer placement (HSP) minimizes rectal dose during prostate cancer radiation therapy, its potential benefit for modulating rectal toxicity could depend on the achieved prostate-rectal separation. We therefore developed a q
Externí odkaz:
https://doaj.org/article/3268af5e2160445b81ff50e7833a90da
Autor:
Roche Kapoor, Matthew P. Deek, Riley McIntyre, Natasha Raman, Megan Kummerlowe, Iyah Chen, Matt Gaver, Hao Wang, Sam Denmeade, Tamara Lotan, Channing Paller, Mark Markowski, Michael Carducci, Mario Eisenberger, Tomasz M. Beer, Daniel Y. Song, Theodore L. DeWeese, Jason W. Hearn, Stephen Greco, Curtiland DeVille, Neil B. Desai, Elisabeth I. Heath, Stanley Liauw, Daniel E. Spratt, Arthur Y. Hung, Emmanuel S. Antonarakis, Phuoc T. Tran
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background In men with a rising PSA following radical prostatectomy, salvage radiation therapy (SRT) offers a second chance for cure. Hormonal therapy can be combined with SRT in order to increase prostate tumor control, albeit with associat
Externí odkaz:
https://doaj.org/article/2eb48a9b5d9f4772a8b098572c4cd10f
Autor:
Phuoc T. Tran, Kathryn Lowe, Hua-Ling Tsai, Daniel Y. Song, Arthur Y. Hung, Jason W.D. Hearn, Steven Miller, James A. Proudfoot, Matthew P. Deek, Ryan Phillips, Tamara Lotan, Channing J. Paller, Catherine H. Marshall, Mark Markowski, Shirl Dipasquale, Samuel Denmeade, Michael Carducci, Mario Eisenberger, Theodore L. DeWeese, Matthew Orton, Curtiland Deville, Elai Davicioni, Stanley L. Liauw, Elisabeth I. Heath, Stephen Greco, Neil B. Desai, Daniel E. Spratt, Felix Feng, Hao Wang, Tomasz M. Beer, Emmanuel S. Antonarakis
Publikováno v:
Journal of Clinical Oncology. 41:1307-1317
PURPOSE We sought to investigate whether enzalutamide (ENZA), without concurrent androgen deprivation therapy, increases freedom from prostate-specific antigen (PSA) progression (FFPP) when combined with salvage radiation therapy (SRT) in men with re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30416fd4bd0af7ef9c0b0379d0e2b33
https://doi.org/10.1200/jco.22.01662
https://doi.org/10.1200/jco.22.01662
Autor:
Rajal B. Shah, Doreen N. Palsgrove, Neil B. Desai, Jeffrey Gagan, Amanda Mennie, Ganesh Raj, Raquibul Hannan
Publikováno v:
Modern Pathology. 35:1468-1474
Locally relapsed prostate cancer (PCa) after radiation therapy (RT) is associated with substantial morbidity and mortality. Morphological and molecular consequences that may contribute to RT resistance and local recurrence remain poorly understood. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb0d4574ac5a31e4b9c63ecf74016509
https://doi.org/10.1038/s41379-022-01093-9
https://doi.org/10.1038/s41379-022-01093-9
Autor:
Charito Love, Neil B. Desai, Tony Abraham, Kevin P. Banks, Lisa Bodei, Thomas Boike, Richard K.J. Brown, David L. Bushnell, Lorraine E. DeBlanche, Michael M. Dominello, Tony Francis, Erin C. Grady, Robert F. Hobbs, Thomas A. Hope, Jeffrey S. Kempf, Daniel A. Pryma, William Rule, Bital Savir-Baruch, Ila Sethi, Rathan M. Subramaniam, Ying Xiao, Naomi R. Schechter
Publikováno v:
Clinical Nuclear Medicine. 47:503-511
This practice parameter (PP) for Lutetium-177 (Lu-177) DOTATATE peptide receptor radionuclide therapy (PRRT) aims to guide authorized users in selection of appropriate adult candidates with gastroeneropancreatic neuroendocrine tumors (GEP-NETs) from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03653d4bd4791cf4922b6137bae3e3b
https://doi.org/10.1097/rlu.0000000000004182
https://doi.org/10.1097/rlu.0000000000004182
Autor:
Ganesh V. Raj, Benjamin P.C. Chen, Ram S. Mani, Scott M. Dehm, Johann S. de Bono, Sandeep Burma, Felix Y. Feng, Neil B. Desai, Chao Xing, Solomon L. Woldu, Xihui Liu, Ryan Hutchinson, Xiangyi Li, Mohammed S. Kanchwala, Yunpeng Gao, Zhao Liu, Sam Ding, Susmita G. Ramanand, GuemHee Baek, Jeffrey Li, Sentai Ding, Kangling Xu, Rui Li, Yi Yin
ARV mediates DDR and clonogenic survival.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab34a344390b5ee39c68d750fa7a888c
https://doi.org/10.1158/0008-5472.22414325.v1
https://doi.org/10.1158/0008-5472.22414325.v1
Autor:
Ganesh V. Raj, Benjamin P.C. Chen, Ram S. Mani, Scott M. Dehm, Johann S. de Bono, Sandeep Burma, Felix Y. Feng, Neil B. Desai, Chao Xing, Solomon L. Woldu, Xihui Liu, Ryan Hutchinson, Xiangyi Li, Mohammed S. Kanchwala, Yunpeng Gao, Zhao Liu, Sam Ding, Susmita G. Ramanand, GuemHee Baek, Jeffrey Li, Sentai Ding, Kangling Xu, Rui Li, Yi Yin
In prostate cancer, androgen deprivation therapy (ADT) enhances the cytotoxic effects of radiotherapy. This effect is associated with weakening of the DNA damage response (DDR) normally supported by the androgen receptor. As a significant number of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8f14bd1858f8a19b54cb8d7eec7525
https://doi.org/10.1158/0008-5472.c.6508943.v1
https://doi.org/10.1158/0008-5472.c.6508943.v1
Autor:
Barry S. Taylor, Hikmat A. Al-Ahmadie, David B. Solit, Gopa Iyer, Michael F. Berger, Nikolaus Schultz, Dean F. Bajorin, Jonathan E. Rosenberg, Bernard H. Bochner, Charles M. Rudin, Victor E. Reuter, Xueli Hao, Eugene K. Cha, Agnes Viale, Adam Abeshouse, Ritika Kundra, Venkatraman E. Seshan, Ronglai Shen, Nicholas D. Socci, Neil B. Desai, Alexander Penson, Matthew T. Chang
Supplementary Figure 2: Enrichment of biallelic RB1 in SCCBs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ce3613ff5239cdca6e4f648fcc5938
https://doi.org/10.1158/1078-0432.22465017.v1
https://doi.org/10.1158/1078-0432.22465017.v1
Autor:
Barry S. Taylor, Hikmat A. Al-Ahmadie, David B. Solit, Gopa Iyer, Michael F. Berger, Nikolaus Schultz, Dean F. Bajorin, Jonathan E. Rosenberg, Bernard H. Bochner, Charles M. Rudin, Victor E. Reuter, Xueli Hao, Eugene K. Cha, Agnes Viale, Adam Abeshouse, Ritika Kundra, Venkatraman E. Seshan, Ronglai Shen, Nicholas D. Socci, Neil B. Desai, Alexander Penson, Matthew T. Chang
Purpose: Small-cell carcinoma of the bladder (SCCB) is a rare and aggressive neuroendocrine tumor with a dismal prognosis and limited treatment options. As SCCB is histologically indistinguishable from small-cell lung cancer, a shared pathogenesis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23b87f830bbc39b66fd624b78efaa500
https://doi.org/10.1158/1078-0432.c.6525894
https://doi.org/10.1158/1078-0432.c.6525894